Leading Medical Physics Meeting to Feature More than 40 Presentations on ViewRay’s MRIdian MRI-Guided Radiotherapy
UF startup ViewRay, Inc., a company dedicated to giving clinicians new and better ways to treat cancer with radiation therapy, announced that the company’s MRIdian® System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting. AAPM is the largest […]
National Science Foundation Awards TAO Connect $500K Grant to Develop and Launch Its AI-Based Chatbot
UF startup TAO Connect, a digital health company aiming to make behavioral health therapy more accessible and efficient, announced it has received $500,000 from the National Science Foundation (NSF) to launch its artificial intelligence-based chatbot. The addition of the chatbot will provide its users with a more humanized, engaging and personalized experience. “The continued support […]
SharpSpring Recognized As “Top Rated All-in-One Marketing Tool for 2019” by TrustRadius
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform, announced it has been recognized as a Top Rated All-in-One Marketing Tool for 2019 on TrustRadius, the widely-respected B2B software technology review platform. “SharpSpring has earned a Top Rated award for all-in-one marketing platforms,” said Megan Headley, VP of Research at TrustRadius. “These awards are […]
Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56 Percent
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, announced that NP-120, its repurposed lead candidate for the treatment of idiopathic pulmonary fibrosis (IPF), showed superiority in reducing fibrosis over two globally approved therapies for IPF, Pirfenidone and Nintedanib, in a well-established in vivo animal model study of IPF. Learn more about Algernon Pharmaceuticals’ […]
Oxthera Presents Continuous Strong Data from an Interim Analysis of Its Phase 2 Study with Oxabact in Primary Hyperoxaluria
UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company dedicated to improving the lives of people living with Primary Hyperoxaluria (PH), announced continuous strong data from a two-year interim analysis of its Phase 2 study with Oxabact® in PH. OC5-OL-01 is the longest efficacy and safety study of any intervention to lower the oxalate burden […]
Clinipace’s Data Aggregation Solution Will Be Showcased at DIA Annual Meeting
UF startup Clinipace, a global full-service contract research organization (CRO), will showcase Clarity Stack® clinical technology at the 2019 Drug Information Association (DIA) Annual Meeting. Clarity Stack is an innovative clinical and study data aggregation solution that provides an up-to-date perspective of trial progress with visual insights and a holistic view of study-related information. “Most […]
OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria
UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company dedicated to improving the lives of people living with Primary Hyperoxaluria, announced that the first patients in a Phase 3 study of Oxabact® have completed the study and transitioned to an open-label extension part. All clinics participating in the study will continue to treat patients in […]
NASA Invests $45M in US Small Businesses for Space Tech Development
American businesses will help NASA land astronauts on the Moon in five years and establish a sustainable presence there, as part of the agency’s larger Moon to Mars exploration approach. NASA has selected 363 proposals from small businesses and research institutions across 41 states to help advance the types of capabilities needed for those future […]
GuideWell Innovation Selects Six Women-Founded Health Tech Companies for Summer Scale-Up Accelerator Cohort
Sherry Benton, founder of TAO Connect, a company that incubated at UF Innovate | The Hub, has been selected as one of the six health technology companies for the Summer 2019 GuideWell Scale-Up Accelerator cohort. The GuideWell Scale-Up Accelerator is an eight-week technology accelerator program focused on “Scale-Up” health technology or medical device companies. This cohort is dedicated […]
Recent Peer-Reviewed Publication on Oragenics, Inc.’s Lantibiotic Antimicrobial Compound Identifies Alternative Mechanism of Action
UF Innovate | Sid Martin Biotech client Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), announces the publication of a collaborative study investigating an additional mechanism of action of the company’s lantibiotic compounds, which shows the formation of water permeating pores across bacterial […]